Ozanimod has an improved nonclinical safety profile relative to fingolimod S. Meier-Davis,J. Brooks,J. Wilson, K. Dines,E. MartinboroughMULTIPLE SCLEROSIS JOURNAL(2017)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要